NO20080439L - Amylaser til farmasoytisk anvendelse - Google Patents
Amylaser til farmasoytisk anvendelseInfo
- Publication number
- NO20080439L NO20080439L NO20080439A NO20080439A NO20080439L NO 20080439 L NO20080439 L NO 20080439L NO 20080439 A NO20080439 A NO 20080439A NO 20080439 A NO20080439 A NO 20080439A NO 20080439 L NO20080439 L NO 20080439L
- Authority
- NO
- Norway
- Prior art keywords
- amylases
- bacillus
- pharmaceutical use
- diabetes
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500931 | 2005-06-24 | ||
| PCT/DK2006/000354 WO2006136161A2 (en) | 2005-06-24 | 2006-06-16 | Amylases for pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080439L true NO20080439L (no) | 2008-03-04 |
Family
ID=34956782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080439A NO20080439L (no) | 2005-06-24 | 2008-01-23 | Amylaser til farmasoytisk anvendelse |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8017351B2 (pt) |
| EP (1) | EP1896057A2 (pt) |
| JP (1) | JP2008546396A (pt) |
| KR (1) | KR20080031868A (pt) |
| CN (1) | CN101242853A (pt) |
| AU (1) | AU2006261444A1 (pt) |
| BR (1) | BRPI0611932A2 (pt) |
| CA (1) | CA2612811A1 (pt) |
| IL (1) | IL187635A0 (pt) |
| MX (1) | MX2007015471A (pt) |
| NO (1) | NO20080439L (pt) |
| NZ (1) | NZ563737A (pt) |
| RU (1) | RU2008102650A (pt) |
| WO (1) | WO2006136161A2 (pt) |
| ZA (1) | ZA200710644B (pt) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2440249T3 (es) * | 2006-04-04 | 2014-01-28 | Novozymes A/S | Proceso de trituración |
| RU2009128067A (ru) | 2006-12-21 | 2011-01-27 | Новозимс А/С (Dk) | Варианты липаз для их применения в фармацевтике |
| CN101889084A (zh) | 2007-12-04 | 2010-11-17 | 诺维信公司 | 供药学应用的蛋白酶变体 |
| GB2468629B (en) * | 2008-06-08 | 2011-10-26 | Tarig Sayed Mustafa Arbab | Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases |
| CN102438599B (zh) * | 2009-03-04 | 2015-01-21 | 迈雅营养品有限公司 | 通过降低血糖水平来控制糖尿病的营养组合物和方法 |
| WO2011000924A1 (en) | 2009-07-03 | 2011-01-06 | Abbott Products Gmbh | Spray-dried amylase, pharmaceutical preparations comprising the same and use |
| CN102918149A (zh) | 2010-01-04 | 2013-02-06 | 诺维信公司 | α-淀粉酶 |
| US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| US20130273026A1 (en) * | 2012-04-12 | 2013-10-17 | Integrative Enzymatics, Inc. | Composition and method for modulating inflammatory molecules with amylase |
| EP3004341B1 (en) | 2013-05-29 | 2017-08-30 | Danisco US Inc. | Novel metalloproteases |
| EP3110833B1 (en) | 2013-05-29 | 2020-01-08 | Danisco US Inc. | Novel metalloproteases |
| JP6367930B2 (ja) | 2013-05-29 | 2018-08-01 | ダニスコ・ユーエス・インク | 新規メタロプロテアーゼ |
| US20160160202A1 (en) | 2013-05-29 | 2016-06-09 | Danisco Us Inc. | Novel metalloproteases |
| ES2723948T3 (es) | 2013-12-13 | 2019-09-04 | Danisco Us Inc | Serina proteasas procedentes de especies de Bacillus |
| EP3553173B1 (en) | 2013-12-13 | 2021-05-19 | Danisco US Inc. | Serine proteases of the bacillus gibsonii-clade |
| US10005850B2 (en) | 2013-12-16 | 2018-06-26 | E I Du Pont De Nemours And Company | Use of poly alpha-1,3-glucan ethers as viscosity modifiers |
| CN106029700B (zh) | 2013-12-18 | 2019-04-12 | 纳幕尔杜邦公司 | 阳离子聚α-1，3-葡聚糖醚 |
| CN105992796A (zh) | 2014-02-14 | 2016-10-05 | 纳幕尔杜邦公司 | 用于粘度调节的聚-α-1,3-1,6-葡聚糖 |
| CN103789285B (zh) * | 2014-02-19 | 2016-01-20 | 江南大学 | 一种热稳定性提高的淀粉酶突变体及其构建方法和应用 |
| JP2017515921A (ja) | 2014-03-11 | 2017-06-15 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ | 酸化されたポリα−１，３−グルカン |
| US20170096653A1 (en) | 2014-03-21 | 2017-04-06 | Danisco Us Inc. | Serine proteases of bacillus species |
| CN106661564A (zh) | 2014-04-25 | 2017-05-10 | 巴斯夫欧洲公司 | 淀粉酶变体 |
| EP3919599A1 (en) | 2014-06-19 | 2021-12-08 | Nutrition & Biosciences USA 4, Inc. | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| CN104212780A (zh) * | 2014-09-02 | 2014-12-17 | 华东理工大学 | 一种α-淀粉酶及其编码基因与应用 |
| WO2016036834A1 (en) * | 2014-09-02 | 2016-03-10 | Danisco Us Inc. | Dp5-enriched syrups |
| US20170233710A1 (en) | 2014-10-17 | 2017-08-17 | Danisco Us Inc. | Serine proteases of bacillus species |
| WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
| EP3550017B1 (en) | 2014-10-27 | 2021-07-14 | Danisco US Inc. | Serine proteases |
| EP3212781B1 (en) | 2014-10-27 | 2019-09-18 | Danisco US Inc. | Serine proteases |
| EP3212783B1 (en) | 2014-10-27 | 2024-06-26 | Danisco US Inc. | Serine proteases |
| EP3212662B1 (en) | 2014-10-27 | 2020-04-08 | Danisco US Inc. | Serine proteases |
| WO2016106011A1 (en) | 2014-12-23 | 2016-06-30 | E. I. Du Pont De Nemours And Company | Enzymatically produced cellulose |
| EP3872174B1 (en) | 2015-05-13 | 2023-03-01 | Danisco US Inc. | Aprl-clade protease variants and uses thereof |
| ES2962329T3 (es) | 2015-06-09 | 2024-03-18 | Danisco Us Inc | Encapsulados de estallido osmótico |
| WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
| WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
| CN107849549B (zh) | 2015-06-17 | 2024-04-05 | 丹尼斯科美国公司 | 吉氏芽孢杆菌进化枝丝氨酸蛋白酶 |
| WO2017052455A1 (en) | 2015-09-23 | 2017-03-30 | Anara Ab | Amylase fragments for blood glucose control |
| WO2017079751A1 (en) | 2015-11-05 | 2017-05-11 | Danisco Us Inc | Paenibacillus sp. mannanases |
| EP3371307A1 (en) | 2015-11-05 | 2018-09-12 | Danisco US Inc. | Paenibacillus and bacillus spp. mannanases |
| JP7045313B2 (ja) | 2015-11-13 | 2022-03-31 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー，インコーポレイテッド | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
| JP2019504932A (ja) | 2015-11-13 | 2019-02-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
| US10876074B2 (en) | 2015-11-13 | 2020-12-29 | Dupont Industrial Biosciences Usa, Llc | Glucan fiber compositions for use in laundry care and fabric care |
| BR112018011755A2 (pt) | 2015-12-09 | 2018-12-04 | Danisco Us Inc | variantes combinatórias de alfa-amilase |
| WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
| EP3452585A1 (en) | 2016-05-03 | 2019-03-13 | Danisco US Inc. | Protease variants and uses thereof |
| EP3452497B1 (en) * | 2016-05-03 | 2021-02-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding the same |
| BR112018072586A2 (pt) | 2016-05-05 | 2019-02-19 | Danisco Us Inc | variantes de protease e usos das mesmas |
| CN109477112A (zh) | 2016-05-31 | 2019-03-15 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
| EP3251687A1 (en) | 2016-06-01 | 2017-12-06 | Centrum Innowacji Edoradca Sp. z o.o. Spolka Komandytowa | Bioactive peptides for blood glucose control |
| BR112018075933A2 (pt) | 2016-06-17 | 2019-10-01 | Danisco Us Inc | variantes de protease e usos das mesmas |
| GB201614415D0 (en) * | 2016-08-24 | 2016-10-05 | Pepsis Ltd | Enzymes for the treatment of human enterometabolic dysfunction |
| EP3535365A2 (en) | 2016-11-07 | 2019-09-11 | Danisco US Inc. | Laundry detergent composition |
| EP4212622A3 (en) | 2016-12-21 | 2023-11-29 | Danisco US Inc. | Bacillus gibsonii-clade serine proteases |
| WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
| EP3583210B1 (en) | 2017-03-15 | 2021-07-07 | Danisco US Inc. | Trypsin-like serine proteases and uses thereof |
| US20200040283A1 (en) | 2017-03-31 | 2020-02-06 | Danisco Us Inc | Delayed release enzyme formulations for bleach-containing detergents |
| JP2020527339A (ja) | 2017-06-30 | 2020-09-10 | ダニスコ・ユーエス・インク | 低凝集の酵素含有粒子 |
| EP3717643A1 (en) | 2017-11-29 | 2020-10-07 | Danisco US Inc. | Subtilisin variants having improved stability |
| CA3086202A1 (en) | 2017-12-21 | 2019-06-27 | Danisco Us Inc. | Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant |
| US20200359656A1 (en) | 2018-02-08 | 2020-11-19 | Danisco Us Inc. | Thermally-resistant wax matrix particles for enzyme encapsulation |
| WO2019204486A1 (en) * | 2018-04-18 | 2019-10-24 | Baylor College Of Medicine | Development of amyloglucosidase as a medicinal food or dietary supplement |
| US20210214703A1 (en) | 2018-06-19 | 2021-07-15 | Danisco Us Inc | Subtilisin variants |
| WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
| US20210189295A1 (en) | 2018-08-30 | 2021-06-24 | Danisco Us Inc | Enzyme-containing granules |
| CN113166682A (zh) | 2018-09-27 | 2021-07-23 | 丹尼斯科美国公司 | 用于医疗器械清洁的组合物 |
| US20230028935A1 (en) | 2018-11-28 | 2023-01-26 | Danisco Us Inc | Subtilisin variants having improved stability |
| CN114174504A (zh) | 2019-05-24 | 2022-03-11 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| EP3980517A1 (en) | 2019-06-06 | 2022-04-13 | Danisco US Inc. | Methods and compositions for cleaning |
| US20240034960A1 (en) | 2020-08-27 | 2024-02-01 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
| US20240117275A1 (en) | 2021-01-29 | 2024-04-11 | Danisco Us Inc. | Compositions for cleaning and methods related thereto |
| EP4363565A1 (en) | 2021-06-30 | 2024-05-08 | Danisco US Inc. | Variant lipases and uses thereof |
| WO2023034486A2 (en) | 2021-09-03 | 2023-03-09 | Danisco Us Inc. | Laundry compositions for cleaning |
| WO2023039270A2 (en) | 2021-09-13 | 2023-03-16 | Danisco Us Inc. | Bioactive-containing granules |
| WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
| WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
| WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
| WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
| WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
| WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
| US5281526A (en) * | 1992-10-20 | 1994-01-25 | Solvay Enzymes, Inc. | Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof |
| AU6221496A (en) | 1995-05-31 | 1996-12-18 | Simon Lodewijk Scharpe | Composition to improve digestibility and utilisation of nutr ients |
| AU2692897A (en) * | 1996-04-30 | 1997-11-19 | Novo Nordisk A/S | Alpha-amylase mutants |
| EP1023439B1 (en) | 1997-10-13 | 2009-02-18 | Novozymes A/S | alpha-AMYLASE MUTANTS |
| PT1162995E (pt) * | 1999-03-17 | 2003-08-29 | Solvay Pharm Gmbh | Enzimas para o tratamento da diabetes mellitus do tipo i |
| US6410295B1 (en) * | 1999-03-30 | 2002-06-25 | Novozymes A/S | Alpha-amylase variants |
| US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| RU2201763C1 (ru) | 2001-12-29 | 2003-04-10 | Закрытое акционерное общество "Брынцалов-А" | Полиферментное средство ферестал |
| DE10260903A1 (de) * | 2002-12-20 | 2004-07-08 | Henkel Kgaa | Neue Perhydrolasen |
| EP1597363B1 (en) * | 2003-02-26 | 2015-07-15 | Danisco US Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
| BRPI0611936A2 (pt) * | 2005-06-24 | 2011-02-22 | Solvay Pharm Gmbh | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de doença |
| US20090047266A1 (en) * | 2005-06-24 | 2009-02-19 | Novozymes A/S | Lipases for Pharmaceutical Use |
-
2006
- 2006-06-16 BR BRPI0611932-8A patent/BRPI0611932A2/pt not_active IP Right Cessation
- 2006-06-16 MX MX2007015471A patent/MX2007015471A/es not_active Application Discontinuation
- 2006-06-16 KR KR1020077029681A patent/KR20080031868A/ko not_active Application Discontinuation
- 2006-06-16 WO PCT/DK2006/000354 patent/WO2006136161A2/en active Application Filing
- 2006-06-16 CA CA002612811A patent/CA2612811A1/en not_active Abandoned
- 2006-06-16 EP EP06742473A patent/EP1896057A2/en not_active Withdrawn
- 2006-06-16 AU AU2006261444A patent/AU2006261444A1/en not_active Abandoned
- 2006-06-16 JP JP2008517320A patent/JP2008546396A/ja active Pending
- 2006-06-16 RU RU2008102650/13A patent/RU2008102650A/ru not_active Application Discontinuation
- 2006-06-16 CN CNA2006800302221A patent/CN101242853A/zh active Pending
- 2006-06-16 NZ NZ563737A patent/NZ563737A/en not_active IP Right Cessation
- 2006-06-16 US US11/917,551 patent/US8017351B2/en not_active Expired - Fee Related
-
2007
- 2007-11-26 IL IL187635A patent/IL187635A0/en unknown
- 2007-12-06 ZA ZA200710644A patent/ZA200710644B/xx unknown
-
2008
- 2008-01-23 NO NO20080439A patent/NO20080439L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200710644B (en) | 2008-11-26 |
| US8017351B2 (en) | 2011-09-13 |
| CA2612811A1 (en) | 2006-12-28 |
| CN101242853A (zh) | 2008-08-13 |
| RU2008102650A (ru) | 2009-07-27 |
| AU2006261444A1 (en) | 2006-12-28 |
| US20090035293A1 (en) | 2009-02-05 |
| NZ563737A (en) | 2010-08-27 |
| WO2006136161A3 (en) | 2007-07-05 |
| IL187635A0 (en) | 2008-03-20 |
| MX2007015471A (es) | 2008-04-04 |
| BRPI0611932A2 (pt) | 2011-01-04 |
| WO2006136161A2 (en) | 2006-12-28 |
| EP1896057A2 (en) | 2008-03-12 |
| KR20080031868A (ko) | 2008-04-11 |
| JP2008546396A (ja) | 2008-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080439L (no) | Amylaser til farmasoytisk anvendelse | |
| DK1755656T3 (da) | Enzymer til farmaceutisk anvendelse | |
| NO20080438L (no) | Proteaser til farmasoytisk anvendelse | |
| NO20080437L (no) | Lipaser til farmasoytisk anvendelse | |
| NO20092729L (no) | Lipasevarianter for farmasoytisk anvendelse | |
| MX2010005690A (es) | Variantes de proteasa para uso farmaceutico. | |
| WO2005111203A3 (en) | MUTANT α ΑMYLASES | |
| BRPI0915531A2 (pt) | Composição de enzima de sacarificação e método de sacarificação da mesma | |
| GB2511713A (en) | Methods of treating behavioral symptoms of neurological and mental disorders | |
| MX2009009378A (es) | Variantes de alfa-amilasa de especies de bacillus alcalifilico, composiciones que comprenden las variantes de alfa-amilasa, y metodos de uso. | |
| NZ595193A (en) | Modified Proteases That Inhibit Complement Activation | |
| NO20064306L (no) | Laktamer som konformasjonelt begrensede peptidomimetiske inhibitorer | |
| MY183252A (en) | Kallirein 7 modulators | |
| EA201170878A1 (ru) | Полипептиды с ксиланазной активностью | |
| ZA200704247B (en) | Stress tolerant cotton plants | |
| DK1162995T3 (da) | Enzymer til behandling af diabetes mellitus type I | |
| RU2011102781A (ru) | ПРИМЕНЕНИЕ Hsp70 В КАЧЕСТВЕ РЕГУЛЯТОРА ФЕРМЕНТАТИВНОЙ АКТИВНОСТИ | |
| WO2009100348A3 (en) | Peptides and peptide mimetics to treat pathologies associated with eye disease | |
| TNSN07396A1 (en) | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response | |
| WO2007125545A3 (en) | Transmucosal composition | |
| JP2008521906A5 (pt) | ||
| TW200726842A (en) | Mutant glucose dehydrogenase | |
| WO2003086452A3 (en) | Methods of enhancing lysosomal storage disease therapy | |
| AU2007241622A8 (en) | Improved treatment of cystic fibrosis | |
| MX2010002018A (es) | Peptido de cdh3 y agente medicinal que comprende al mismo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |